All blog posts
Total 171 results for
Showing 12 out of 171 results
27 April 2026
The EU Pharma Package is finally here – here's the settled position on key areas
12 March 2026
Snapshot: Key European pharma regulatory, IP and competition developments from 2025 for the pharmaceutical sector
19 January 2026
Where is the UPC after two and a half years - and what to expect in 2026?
15 December 2025
A new era for EU pharmaceutical law: political agreement reached on the reform
03 September 2025
Herbert Smith Freehills Kramer comments for LSIPR on small molecule litigation in the UPC
31 July 2025
EU Regulatory Reform for Medicinal Products: Bolar exemption
21 July 2025
Trends emerging as the UPC enters its third year
13 May 2025
EU Regulatory Reform for Medicinal Products: Changes to MAs, supply, and transparency
30 April 2025
EU Regulatory Reform for Medicinal Products: Review of new regulatory exclusivities
03 July 2024
Council of the EU adopts position on the EU compulsory licensing regulation
02 May 2024
HSF publishes Practical Law practice note on the Unitary Patent
12 April 2024
HSF Patent team named best in Europe by Managing IP
Showing 12 out of 171 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Herbert Smith Freehills Kramer Kewei Joint Operation, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London